Previous investigations of p150,95 (CD11c), the third member of the CD18 membrane glycoprotein family that includes CR3 (Mac-i or CD11b) and LFA-1 (CD11a), had demonstrated that solubilized p150,95 bound to iC3b-agarose in a manner similar to isolated CR3. The current study showed that membrane surface p150,95 also expressed iC3b-receptor activity and was probably the same as the neutrophil receptor for iC3b-or C3dg-coated erythrocytes (EC3bi or EC3dg) that had been previously designated CR4. Normal neutrophil and macrophage CR4-dependent EC3bi rosettes were inhibited by monoclonal anti-pl5,95, and cells from a patient with CD18 deficiency did not form CR4-dependent EC3bi rosettes. With neutrophils that bore large amounts of CRI and CR3 and little p150,95, EC3bi were bound primarily via CRI and CR3, and demonstration of p150,95-dependent rosettes required large amounts of fixed iC3b, low-ionic strength buffer, and antibody blockade of CR1 and CR3. By contrast, culture-derived macrophages expressed eight times more p150,95 than did monocytes and EC3bi were bound to both p150,95 and CR3 when EC3bi bore small amounts of fixed iC3b and assays were carried out in isotonic buffer. Comparison of the amounts of CRI, CR3, and CR4 in various tissues by immunoperoxidase staining revealed that CR4 was the most abundant C3 receptor molecule on tissue macrophages, and suggested that CR4 might be involved in clearance of C3-opsonized particles or immune complexes.
Introduction
The membrane glycoprotein p 150,95 (CDlIc; 150 kD a-chain linked noncovalently to 95 kD p3-chain) is expressed on phagocytic cells, natural killer (NK)' cells, and certain cytotoxic T buffer consisting of 1% bovine serum albumin (BSA)/3.2% dextrose/ 3.5 mM veronal buffer pH 7.2/10 mM sodium chloride/10 mM socells (1-3). The 95 kD (i-chain (CD18) is structurally identical to the ,B-chains of two other related leukocyte membrane glycoproteins, LFA-l (lymphocyte function-associated antigen 1 or CDl la) and CR3 (complement receptor type 3, Mac-l, or CDl lb) that have structurally distinct a-chains of 175 and 165 kD, respectively (4) . Much interest has focused on this family of three surface glycoproteins ("CD18 complex") with the identification of several patients who have an inherited deficiency of the entire CD18 complex and suffer from recurrent bacterial infections (4) (5) (6) . Recently, nucleotide sequence analysis has indicated that the three members of the CD18 complex are members of a larger supergene family of seven other membrane glycoproteins that includes the five VLA glycoproteins, the vitronectin receptor and platelet glycoprotein GPIIb/IIIa (7) (8) (9) . All ten of these glycoproteins are either receptors or have adhesion-related functions, and several of the ligands for the receptors that have been characterized are bound via a similar Arg-Gly-Asp (RGD) tripeptide structure (10). Among CD18 family members, CR3 has been shown to recognize an RGD peptide within iC3b (1 1) .
The functions of p 150,95 are just beginning to be defined. Examination ofCD1 8-deficient neutrophils or normal neutrophils treated with antibodies specific for individual a-or #-chains suggests that both CR3 and p150,95 have common functions in mediating neutrophil and monocyte adherence to protein-coated glass (12) and endothelial cells (13, 14) . Furthermore, the adherence step involved in conjugate formation between cytotoxic T cells and target cells has recently been shown to be inhibitable by antibodies to the a-chain of p1 50,95 (15) as well as by antibodies to the a-chain of LFA-1 (16) or the common a-chain (15, 16) . With neutrophils and freshly isolated monocytes that express large amounts of CR3 and small amounts of p150,95 and LFA-1, CR3 has been shown to be the major receptor for fixed iC3b (17, (18) (19) (20) . Recently, however, detergent solubilized p150,95 from U937 cells was shown either to coelute with CR3 from iC3b-agarose affinity columns (21) , or to be purified on iC3b-agarose after selective removal of CR3 by immunoprecipitation (22) , sug-anti-p 1 50,95 inhibitable iC3b-receptor activity on intact cells had been unsuccessful (2, 22) .
In the current study, a receptor for fixed iC3b on sheep erythrocytes (EC3bi) was demonstrated on neutrophils and monocyte-derived macrophages that was not inhibited by a polyclonal mixture of anti-CR1 and anti-CR3 antibodies. This receptor activity on neutrophils appears to be the same as the receptor for EC3bi and EC3dg rosettes that had been previously designated CR4 (23). CR4 activity was weak and variable on neutrophils and freshly isolated monocytes, and seemed to correspond to low levels of p150,95 expression. By contrast, macrophages generated by 7-d culture of monocytes expressed avid CR4 rosetting activity and large amounts of p150,95. With both cell types, CR4 rosetting activity was inhibited by antibodies to the a-chain of p150,95, suggesting that cell surface p150,95 is probably identical to CR4.
Methods
Neutrophils and monocytes. Blood was obtained from normal volunteers or a patient with inherited deficiency of LFA-I/CR3/pl 50,95 (5) . Mononuclear cells were isolated by dextran sedimentation and FicollHypaque centrifugation (24), and cultured for 7 d, either as nonadherent cells in Teflon beakers (25) , or as adherent cells in either 24-well plates (24, 26) or 4-well Lab-Tek slide chambers (Miles Scientific, Naperville, IL). For the slide chambers, 2 X 106 mononuclear cells were added to each well. Cells cultured for 7 d in Teflon beakers were transferred to slide chambers coated with either mouse myeloma IgG or monoclonal antibodies (MAbs) (19, 25) . Lymphocytes were removed by this adherence step. Neutrophils were prepared either from the Ficoll-Hypaque pellet generated during monocyte isolation (using ammonium chloride for lysis of erythrocytes), or by two-step FicollHypaque gradients (17) . Neutrophils were tested either in suspension or after allowing adherence for 1 h to 8-well slide chambers (5 X 105 neutrophils/well in 200 Ml of Hanks' balanced salt solution containing 1% bovine serum albumin; HBSS/BSA).
Antibodies. Rabbit F(ab')2 anti-CR1 was used to block CR1 rosettes (27) , and El1 MAb anti-CR1 was used to quantitate CR1 expression (28) . MAbs to CR3 a-chain included MN-41 (20, 29) , from Dr. Alfred Michael and Dr. Allison Eddy (University of Minnesota, Minneapolis), anti-Mac-1 (18), hybridoma provided by Dr. Timothy Springer (Dana-Farber Cancer Institute, Boston, MA), anti-Mo 1 (30), from Dr. Robert Todd (University of Michigan, Ann Arbor), and the IgG, MAb 44 (22) . MAbs to p 150,95 a-chain included anti-Leu M5 (2) and L29 from Dr. Lewis Lanier of Becton Dickinson Monoclonal Center (Mountain View, CA), and the IgG, mAb 3.9 (31). L29 is an IgGI MAb that was generated by immunization of Balb/c mice with human peripheral blood lymphocytes enriched for NK cells by Percoll density gradient centrifugation (32). Immune splenocytes were fused with SP2/0 Ag14 myeloma cells, and hybridomas were selected in azaserine. L29 has been designated as CDl lc reactive (33) on the following basis: (a) identical size a-and a-chains precipitated by L29 and anti-Leu M5, (b) identical immunofluorescence flow cytometry histogram as antiLeu M5 with neutrophils and mononuclear cells, (c) absent fluorescence staining of cells from two patients with inherited deficiency of LFA-l/CR3/pl50,95, (d) inhibition of EC3bi rosettes in a manner similar to both anti-Leu M5 and 3.9. The epitope specificity of antip 150,95 MAbs was evaluated by cross-blocking experiments in which one MAb labeled with 1251I was tested for uptake onto neutrophils or U937 cells that had been incubated with a 100-fold molar excess of unlabeled homologous or nonhomologous MAb (34 (35) . Each monoclonal immunoglobulin (except for those received as IgG) was purified from ascites fluid or culture supernatant by high performance liquid chromatography using cation exchange (Protein Pak SP-5PW; Waters Associates, Milford, MA) with 10 mM sodium acetate pH 5.5 and a sodium chloride gradient, followed by anion exchange (Protein Pak DEAE-5PW; Waters Associates) with 20 mM Tris/HCl pH 8.5 and a sodium chloride gradient (36) .
Preparation ofEC3. EC3b and EC3bi were prepared as previously described, followed by analysis of bound C3 fragments with '25I-labeled MAbs to C3c, C3g, and C3d (17) . For assays of neutrophils and monocytes, EC3bi with 4.5-6.5 X 104 molecules of iC3b/E were used. With monocyte-derived macrophages, EC3bi with 1.2-1.8 X I04 molecules of iC3b/E were used.
EC3 rosette assay. Neutrophils in suspension were tested for rosettes as before (17) . Adherent neutrophils or monocytes in 8-well slide chambers were washed three times and reconstituted with 140 Ml/well of low-ionic strength BDVA buffer (1% BSA/3.2% dextrose/3.5 mM veronal buffer/10 mM sodium chloride-/10 mM sodium azide/2 mM each of calcium chloride and magnesium chloride, pH 7.2, 4.5 mS at 22°C). With macrophages in 4-well chambers, 225 Al of isotonic HBSS/BSA was used instead of BDVA. Next, 100 ul of EC3bi (2 X 108/ml in BDVA or HBSS/BSA) was added to each well, and after 15 min at 37°C, the wells were washed to remove unbound EC3bi, the partitioned top chamber was removed, and a 50 X 22 mm coverslip was placed over the adherent cells on the glass slide. Rosettes were observed by phase contrast microscopy with cells bearing 2 4 bound EC3bi scored as positive. Neutrophil assays included 1 mg/ml of soybean trypsin inhibitor (Sigma Chemical Co., St. Louis, MO) to prevent elastase proteolysis of iC3b on the EC3bi (37) .
For studies of antibody blockade of rosettes, adherent phagocytes were incubated for 20 min with antibodies, the volume was brought up to 140 ,ul (8-well chambers) or 225 Ml (4-well chambers) with buffer, and 100,l ofEC3bi were added for rosette assay without washing away unbound antibodies. With neutrophils in suspension, assays were also carried out with excess fluid phase antibodies (20) . The amount of F(ab')2 anti-CR, used was sufficient to block all monocyte and neutrophil rosettes with EC3b (17) . To determine the appropriate amount of each anti-CR3 MAb, titrations for inhibition of rosette formation were carried out with each phagocytic cell type (results shown for adherent neutrophils only, Fig. 1 ). For subsequent assays of CR4 rosetting activity, amounts of anti-CR3 MAbs were used that were 4-to 10-fold greater than the amounts producing maximum plateau levels ofinhibition of EC3bi rosette formation in the presence or absence of excess rabbit F(ab')2 anti-CR1 . As an alternative procedure for demonstration ofpl 50,95-dependent rosettes, surface p150,95 on monocytes cultured for 7 d in Teflon beakers was modulated from the apical surfaces of cells by 45 min cultivation in slide chambers coated with monoclonal anti-pl50,95 attached via poly L-lysine and glutaraldehyde (19, 25) . Surfaces coated with MAb anti-CR3, anti-MHC class I, or myeloma IgG served as controls. MAbs to CR3 and/or p1 50,95 were then added in the fluid phase prior to EC3bi addition.
Quantitation ofCR,, CR3, andp150,95. Neutrophils were tested in suspension for uptake of '251I-MAbs (34) . Serial dilutions of '251-MAbs Tables I-IV were sufficient to produce plateau levels of inhibition of CR3 rosetting activity.
buffer for 20 min at 40C, and then incubated with '251-labeled MAb for 20 min at 40C. After four washes with HBSS/BSA, cells with bound 1251I-MAb were eluted for gamma scintillation counting with I ml of 0.05% Triton X-100, 1 ml of HBSS/BSA, and vigorous pipetting.
Immunoperoxidase labeling ofmonocytes and tissue sections. The following fresh-frozen tissues were obtained from the Imperial Cancer Research Fund Department of Histopathology: tonsil, spleen, thymus, lung, skin, brain, bronchus, and colon. All tissues were judged to be normal by histopathologists, with the exception of reactive tonsils, which were removed after antibiotic therapy of patients. All tissues were obtained from adults except tonsil and thymus obtained from children. Glass-adherent monocytes and 6 Mm sections of acetonefixed fresh-frozen tissues were subjected to indirect immunoperoxidase staining with MAbs as previously reported (28, 31) . Briefly, samples were incubated at room temperature for 30 min with 50 Ml of various IgG, MAb-containing supernatants, followed, after appropriate washing by 40 MAl ofperoxidase-conjugated goat antimouse immunoglobulin (1:100; Dakopatts, Copenhagen, Denmark). A positive reaction was revealed by a 7-min exposure to hydrogen peroxide (0.0 12%) and 3,3'-diaminobenzidene (0.6 mg/ml). Controls for the IgG1 MAbs El 1, 44 and 3.9 were a nonspecific IgG, MAb and omission of first layer antibodies.
Results
Expression ofCR4-dependent rosettes. CR4-dependent rosettes were defined as EC3bi rosettes with neutrophils or monocytes that had been treated with amounts of anti-CR1 and anti-CR3 that were sufficient to inhibit CRI-and CR3-dependent rosettes completely. With neutrophils, such CR4-dependent rosettes had been previously shown (23) to require > 45,000 molecules of iC3b or C3dg per EC3bi or EC3dg and a lowionic strength buffer (BDVA). When neutrophils were examined for such CR4-dependent rosettes in the present study, it was found that some of the rosettes formed in the presence of rabbit anti-CR, and saturating amounts of MN-41 anti-CR3 could be blocked by further treatment of cells with saturating amounts of a second and/or third anti-CR3 MAb such as antiMol and/or anti-Mac-l (Fig. 1) . For this reason, subsequent tests of putative CR4-dependent rosettes were carried out with a mixture of rabbit anti-CR1 and three anti-CR3 MAbs (MN-4 1, anti-Mac-1, anti-Mo 1). When tested in this way, neutrophils from 6 of 14 donors formed . 15% CR4-dependent rosettes, i.e., nearly all rosettes were abolished by the anti-CR I/CR3 mixture. The results given in Table I are for the eight remaining neutrophil preparations giving . 23% CR4-dependent rosettes, as only these preparations were judged satisfactory for tests for inhibition of rosettes by anti-p 150,95.
Freshly isolated monocytes tested on four occasions formed only 6-14% CR4-dependent rosettes and so were not examined further. By contrast, macrophages generated by cultivation of adherent monocytes for 7 d formed much higher proportions of CR4-dependent rosettes, even when EC3bi contained as few as 12,000 iC3b per E and assays were carried in isotonic buffer (Table II) Because the anti-p150,95 MAbs produced only partial in- Absence of CR4-dependent rosettes with neutrophils and monocyte-derived macrophages from a patient with partial deficiency ofthe LFA-J/CR3/pJ50,95 membrane antigenfamily.
Normal neutrophils, tested in parallel with the patient's neutrophils, formed 23% CR4-dependent EC3bi rosettes that were reduced to 8 and 2% by anti-Leu M5 and 3.9, respectively (Table IV) . The patient's neutrophils did not express CR4 activity, because all of the EC3bi rosettes formed in low-ionic strength BDVA buffer were blocked by the anti-CRI /CR3 mixture. Tests of this patient's neutrophils revealed 6,300 CR3 per neutrophil (-10% of normal) by assays for uptake of 1251I-anti-CR3, whereas no expression of p1 50,95 antigens was observed (data not shown).
Monocytes from the patient and a normal control were analyzed after being cultured nonadherently for 7 d. As found before (Table III) , the CR4 rosetting activity ofthe normal cells was inhibited by anti-p 1 50,95 present on surfaces onto which nonadherently grown monocytes were allowed to attach (Table IV) . By contrast, no EC3bi rosettes were observed when the patient's monocytes were examined under the same assay conditions that generated 99% EC3bi rosette formation with the normal monocyte control (Table IV) .
Comparison ofthe amounts ofCR,, CR3, and p150,95 on neutrophils, monocytes, and macrophages. The relative CR4 dependence of EC3bi rosette formation appeared to correlate with the level of surface p1 50,95 versus the levels of CR1 and CR3 (Table V) Fig. 2 , the p150,95-positive labeling of tissue macrophages in thymic medulla (Fig. 2 a) and spleen white pulp (Fig. 2 d) is compared with the lack of staining for CR1 and CR3 on the same cells (Fig. 2 b, c, e, f) . Strong expression of CRI was evident in lymphoid tissues, but it was restricted to lymphocytes (probably B cells, Fig. 2f ) and dendritic reticulum cells. CR3 was also readily detectable on tissue granulocytes (polymorphonuclear cells, Fig. 2 e) . In Fig. 3 , the p150,95 expressing spleen white pulp macrophages (Fig. 3 a) are compared to the CR3-positive granulocytes found within the spleen marginal zone (Fig. 3 b) . Another comparable situation was seen in the tonsil where p150,95 expressing macrophages were found in interfollicular areas (Fig. 3 c) and germinal centers (Fig. 3, c,  e) , whereas CR3-expressing granulocytes were seen in blood vessels (Fig. 3, d: see arrow) , or in situations of inflammation where they were found in large numbers in the tonsil, particularly in the trabecular areas. The general tissue macrophage pattern of strong expression of pl 50,95 compared to CR3 is in contrast to the expression of these molecules by monocytes and neutrophils which exhibited only moderate expression of p150,95 (Fig. 3 f) compared to CR3 (Fig. 3 g ). Various tissues that contained p1 50,95-expressing macrophages are illustrated in Fig. 4 . Both alveolar macrophages and skin macrophages expressed CR3 at much lower levels than p150,95. Although macrophages from bronchus stained predominantly for CR3 rather than for p150,95, additional staining for CD14 suggested that these were probably immature cells (38) despite their large size (data not shown).
Discussion
The current study showed that membrane surface p150,95 expressed the same type of iC3b-receptor activity that had been previously demonstrated with the detergent-solubilized (14, 42) . In contrast, the C3dg-dimer receptor is present on platelets and absent from monocytes (40) . The possible specificity of CR4 for fixed C3dg was not investigated in the present study because of the difficulty in obtaining EC3dg that were totally free of fixed iC3b. EC3dg usually bear 5-10% contamination with fixed iC3b detectable with 1251I-monoclonal anti-C3c (17) . If such EC3dg form rosettes that are not inhibitable by mixtures of anti-CR, and anti-CR3 (23), then it can not be excluded that such CR4-dependent rosettes might be due to this small amount of fixed iC3b. Quantitatively, however, such 10% contamination with iC3b would amount to < 6,000 iC3b molecules on EC3dg bearing 60,000 total fixed iC3b/C3dg molecules, and EC3bi specifically prepared with this amount of fixed iC3b did not form neutrophil CR4-dependent rosettes (23). Although C3dg can be obtained free of iC3b in the fluid-phase, available data suggests that the C3dg-dimers or C3dg-coated microspheres generated from such pure C3dg probably do not bind to CR4, as their uptake by neutrophils is unaffected by EDTA (17, 41) . It is thus likely that the analysis of CR4 binding of C3dg will require indicator particles bearing only C3dg fixed via its physiologic ester bond site.
The data presented here and in previous reports (14, 31, 43, 44 ) support the concept that monocytes undergo a switch in C3-receptor types from CRI and CR3 (Mac-l) to CR4 (pl50,95) during differentiation into macrophages. Quantitation of surface antigens with '25I-MAbs showed that culturederived macrophages expressed eight times more CR4 than freshly isolated monocytes. Although this greatly facilitated tests ofthe p 150,95 relationship to CR4, the data suggests that the differentiation of C receptor phenotypes produced in vitro is different from that of normal resting macrophages because CRI and CR3 were also increased on the culture-derived macrophages. When tissue macrophages from several organs were examined by immunoperoxidase staining, the majority of macrophages stained for CR4 (p150,95) and failed to stain for CR1 and CR3. Normally there was little CR3 on tissue macrophages in combination with strong expression of CR4. Much larger amounts of CR3 have been observed in inflammatory tissues containing granulocyte and monocyte infiltrates, such as those frequently seen in synovial tissues from patients with rheumatoid arthritis (45) .
Preliminary findings further suggest that CR4 can acquire the ability to induce ingestion of EC3bi in a manner similar to CR3. Adherent culture-derived macrophages ingested EC3bi after blockade of CR1 and CR3, and then this CR4 dependent ingestion was inhibited by anti-p 150,95. Others have also reported that p 150,95 (as well as CR3 and LFA-1) could mediate phagocytosis of unopsonized bacteria and yeast (46, 47) .
IfCR4 is primarily expressed and functional on tissue macrophages rather than on blood phagocytes, then characterization of its activity will be more difficult than previous functional studies ofCR1 and CR3. It will be particularly important to determine whether CR4 mediates clearance of iC3b-coated complexes in the liver. 
